INTERNATIONAL MYELOMA SOCIETY (EIN 264220253) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

PHILIPPE MOUREAU

Phone

6176325272

Tax Period

2023-01-01 to 2023-12-31

INTERNATIONAL MYELOMA SOCIETY, founded in 2008, is a mid-sized nonprofit in the Medical Research sector that reported $11.4M in total revenue in fiscal year 2023. The organization ran a surplus of $2.0M, a strong 17% operating margin.

Mission

THE INTERNATIONAL MYELOMA SOCIETY (IMS) IS A PROFESSIONAL, SCIENTIFIC,AND MEDICAL SOCIETY ESTABLISHED TO BRING TOGETHER CLINICAL ANDEXPERIMENTAL SCIENTISTS INVOLVED IN THE STUDY OF MYELOMA. THE PURPOSEOF THIS SOCIETY IS TO PROMOTE RESEARCH, EDUCATION, CLINICAL STUDIES (INCLUDING DIAGNOSIS AND TREATMENT), WORKSHOPS, CONFERENCES AND SYMPOSIA ON ALL ASPECTS OF MULTIPLE MYELOMA AND RELATED DISORDERS WORLDWIDE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $11,428,850

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $11,428,850

Expense Breakdown

Grants Paid $3,277,910

Salaries & Benefits $74,702

Fundraising Expenses $0

Program Expenses $9,378,099

Other Expenses $6,092,360

TOTAL EXPENSES $9,444,972

Year-over-Year Comparison

	2023	2022	Change
Revenue	$11,428,850	$11,526,078	0.0%
Expenses	$9,444,972	$9,371,325	+0.0%
Net Income	$1,983,878	$2,154,753	-0.1%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NIKHIL C MUNSHI	President	1.00	Officer Director	$0	$0	$0
SHAJL KUMAR	Treasurer	1.00	Officer Director	$0	$0	$0
MARLA-VICTORIA MATEOS PASEO	Secretary	1.00	Officer Director	$0	$0	$0
PHILIPPE MOREAU	Vice President	1.00	Officer Director	$0	$0	$0
DOROTEA FANTL	Director	1.00	Director	$0	$0	$0
FRANCESCA GAY	Director	1.00	Director	$0	$0	$0
PJOY HO	Director	1.00	Director	$0	$0	$0
AMRITA KRISHNAN	Director	1.00	Director	$0	$0	$0
SUNDAR JAGANNATH	Director	1.00	Director	$0	$0	$0
PANKAJ MALHOTRA	Director	1.00	Director	$0	$0	$0
SONJA ZWEEGMAN	Director	1.00	Director	$0	$0	$0
KENNETH C ANDERSON	Honorary Board	1.00	Director	$0	$0	$0
ROBERT A KYLE	Honorary Board	1.00	Director	$0	$0	$0
JESUS SAN MIGUEL	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$11,428,850	$9,444,972	$8,793,580	$1,983,878
2022	$3,584,528	$2,623,443	$8,333,584	$961,085
2021	$4,469,545	$1,839,048	$7,371,497	$2,630,497
2020	$2,311,447	$114,818	$4,735,356	$2,196,629
2019	$4,263,040	$3,409,562	$2,564,663	$853,478

INTERNATIONAL MYELOMA SOCIETY